- GlobeNewswire•14 hours ago
Rockwell Medical Announces Poster Presentation and Oral Presentation on Triferic at the 7th Congress of the International BioIron Society May 7 – 11, 2017
WIXOM, Mich., April 27, 2017-- Rockwell Medical, Inc., a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products for the treatment ...
- Business Wire•7 days ago
Richmond Brothers, Inc., a Michigan-based SEC registered investment advisor and wealth management firm that is the largest beneficial owner of Rockwell Medical, Inc. , and Mark H.
- GlobeNewswire•7 days ago
Mails Letter to Shareholders Highlighting Substantial Commercial Progress and Importance of Electing a Director with Relevant Pharmaceutical Expertise. Urges Shareholders to Vote“ FOR” Rockwell Medical’ ...
RMTI: Summary for Rockwell Medical, Inc. - Yahoo Finance
Rockwell Medical, Inc. (RMTI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
|Ask||8.62 x 6000|
|Day's range||8.39 - 8.64|
|52-week range||3.55 - 10.58|
Trade prices are not sourced from all markets
|PE ratio (TTM)||-22.05|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|